Back to search

United Kingdom· GB-APID-39931511000001107

Cutaquig 2g/12ml solution for injection vials

A medicinal product containing normal immunoglobulin human, registered in United Kingdom by Octapharma Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCutaquig 2g/12ml solution for injecti…ATC—REGISTER NO.GB-APID-3993151100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Normal immunoglobulin human
Manufacturer
Octapharma Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060237671287

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af75673f-acd2-4f8f-b422-9d4c11bae91a
GET /v1/drugs/af75673f-acd2-4f8f-b422-9d4c11bae91a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "39931511000001107",
  "desc": "Cutaquig 2g/12ml solution for injection vials (Octapharma Ltd)",
  "form": "Solution for injection",
  "vpid": "32466911000001108",
  "source": "dmd",
  "vtm_id": "776947000",
  "strength": "165 mg",
  "substance": "Normal immunoglobulin human",
  "ingredient": "Normal immunoglobulin human",
  "supplier_code": "2080601000001107"
}

See everything about normal immunoglobulin human.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.